FIELD: medicine.
SUBSTANCE: invention relates to using antagonist of EP4 receptors in preparing a medicinal preparation used in treatment of IL-6-mediated disease chosen from the group including alcoholic cirrhosis, amyloidosis, atherosclerosis, cardiac disease, sclerosis and responses in transplantation of organs.
EFFECT: valuable medicinal properties of ligands.
6 cl, 8 dwg, 380 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED HETEROCYCLIC COMPOUNDS | 2006 |
|
RU2408586C2 |
5-HYDROXYPYRIMIDINE-4-CARBOXAMIDE DERIVATIVE | 2010 |
|
RU2550693C2 |
ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | 2011 |
|
RU2535671C1 |
7-SUBSTITUTED INDOLE Mcl-1 INHIBITORS | 2008 |
|
RU2473542C2 |
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
NOVEL COMPOUNDS OF CONDENSED IMIDAZOLE POSSESSING OF CB2 RECEPTOR AGONIST PROPERTY | 2002 |
|
RU2312864C2 |
DIAMINE DERIVATIVES | 2002 |
|
RU2314303C2 |
NEW 2-HETEROARYL-SUBSTITUTE BENZIMIDAZOLE DERIVATIVE | 2004 |
|
RU2329261C2 |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS | 2013 |
|
RU2635917C2 |
PYRAZOLO[1,5-A]PYRIDINES AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | 2002 |
|
RU2308457C2 |
Authors
Dates
2006-10-20—Published
2003-04-03—Filed